# Oxytocin Bolus Versus Infusion in High-Risk Patients Undergoing Elective Cesarean Section (INBOX-HR)

> **NCT07688512** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Stony Brook University** · enrollment: 180 (estimated)

## Conditions studied

- Postpartum Hemorrhage
- Uterine Atony
- Uterine Atony With Hemorrhage
- Elective Cesarean Section

## Interventions

- **DRUG:** Oxytocin Bolus or Oxytocin Infusion

## Key facts

- **NCT ID:** NCT07688512
- **Lead sponsor:** Stony Brook University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08
- **Primary completion:** 2028-08
- **Final completion:** 2029-02
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2026-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07688512

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07688512, "Oxytocin Bolus Versus Infusion in High-Risk Patients Undergoing Elective Cesarean Section (INBOX-HR)". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07688512. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*